Chimeric pancreas
Abstract
Novel methods, tissues and compositions for increasing the pancreatic mass of a mammalian recipient including harvesting immature pancreatic tissue from a mammalian donor and transplanting said tissue into the peritoneal cavity of a mammalian recipient under conditions that allow the pancreatic tissue to become vascularized and mature, thereby developing a functioning chimeric, endocrine pancreas that produces at least insulin in the recipient. The invention also includes mammalian immature pancreatic tissue adapted for transplantation into the peritoneal cavity of a mammalian recipient for increasing the pancreatic mass of the mammalian recipient as well as methods and compositions for treatment of the pancreatic tissue, recipient immunosuppression and recipient co-stimulatory blockade.
Claims
exact text as granted — not AI-modified1 . Mammalian immature pancreatic tissue adapted for transplantation into the peritoneal cavity of a mammalian recipient for increasing the pancreatic mass of the mammalian recipient, said tissue comprising at least one non-digested, non-disassociated portion of at least one substantially nonvascularized pancreas anlage at least substantially free of antigen presenting cells.
2 . The tissue of claim 1 wherein said tissue is adapted for transplantation by preparing it for or maintaining it in the cold prior to transplantation and after harvesting.
3 . The tissue of claim 1 wherein said tissue is adapted for transplantation by contacting said tissue with growth factors.
4 . The tissue of claim 1 wherein said tissue comprises at least one ventral pancreas anlage.
5 . The tissue of claim 1 wherein said tissue comprises at least one dorsal pancreas anlage.
6 . The tissue of claim 1 wherein said tissue comprises at least one whole pancreata.Join the waitlist — get patent alerts
Track US2008318202A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.